Stereotaxis to Report Second Quarter 2024 Financial Results on August 12, 2024
July 22, 2024 16:05 ET
|
Stereotaxis, Inc.
ST. LOUIS, July 22, 2024 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that it will...
Stereotaxis Strengthens Board of Directors with Appointment of Nachum Shamir
July 18, 2024 16:13 ET
|
Stereotaxis, Inc.
ST. LOUIS, July 18, 2024 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer in surgical robotics for minimally invasive endovascular intervention, today announced the appointment of Nachum...
Penn Presbyterian Medical Center Becomes First Hospital in the Northeast to Adopt Advanced Robotic Technology for Heart Treatment
May 29, 2024 08:25 ET
|
Stereotaxis, Inc.
The most advanced robotic cardiac ablation lab opens at Penn Presbyterian Medical Center.
Stereotaxis Receives CE Mark Recertification Under EU’s MDR Regulatory Framework
May 24, 2024 08:37 ET
|
Stereotaxis, Inc.
Stereotaxis has received CE Mark recertification under the EU’s new Medical Device Regulation (MDR) regulatory framework for all available devices.
First Heart Rhythm Patients in Southern Italy Treated with Advanced Robotic Technology
May 22, 2024 08:42 ET
|
Stereotaxis, Inc.
Hospital Santa Maria della Pietà, in Nola in the Metropolitan City of Naples, has established the first robotic cardiac heart program in Southern Italy.
Stereotaxis Invited by Africa Heart Rhythm Association to Present its Innovative Robotic Solution to Expand High-Quality Therapy in Underserved Regions of Africa
May 15, 2024 08:52 ET
|
Stereotaxis, Inc.
Stereotaxis presents innovative proposal leveraging advanced robotic technology and telerobotic presence to sustainably offer high-quality cardiac ablati
Stereotaxis Reports 2024 First Quarter Financial Results
May 13, 2024 16:03 ET
|
Stereotaxis, Inc.
ST. LOUIS, May 13, 2024 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today reported financial...
Stereotaxis Announces Definitive Agreement to Acquire Access Point Technologies
May 13, 2024 16:02 ET
|
Stereotaxis, Inc.
ST. LOUIS, May 13, 2024 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that it has...
Stereotaxis to Report First Quarter 2024 Financial Results on May 13, 2024
April 22, 2024 07:51 ET
|
Stereotaxis, Inc.
Stereotaxis will host first-quarter financial results on May 13, 2024.
Stereotaxis Announces Regulatory Submissions of the MAGiC Ablation Catheter in Europe and the United States
March 04, 2024 16:06 ET
|
Stereotaxis, Inc.
ST. LOUIS, March 04, 2024 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that...